ACAD three-lens brief
Evidence-based stock research on ACAD. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
50-day MA above 200-day MA (golden-cross regime); price above both.
- 50-day MA above 200-day MA (golden-cross regime); price above both.
- Analyst mean target $34.00 — 23% above current (20 analysts).
ACAD closed at $27.74 (+0.22%) as of 2026-09-11. Market cap: $4.75B. P/E (trailing) 12.4. Price is above the 50-day MA and above the 200-day MA. Positives: 50-day MA above 200-day MA (golden-cross regime); price above both.; analyst mean target $34.00 — 23% above current (20 analysts).. Last quarter: Revenue $307.96M, net income $31.50M, free cash flow $68.65M.
Why three lenses on ACAD, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ACADacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/ACAD" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ACAD brief"></iframe>